We have located links that may give you full text access.
Surface-engineered quantum dots/electrospun nanofibers as a networked fluorescence aptasensing platform toward biomarkers.
Nanoscale 2017 November 10
A membrane-based fluorescent sensing platform is a facile, point-of-care and promising technique in chemo/bio-analytical fields. However, the existing fluorescence sensing films for cancer biomarkers have several problems, with dissatisfactory sensitivity and selectivity, low utilization of probes encapsulated in films as well as the tedious design of membrane structures. In this work, a novel fluorescence sensing platform is fabricated by bio-grafting quantum dots (QDs) onto the surface of electrospun nanofibers (NFs). The aptamer integrated into the QDs/NFs can result in high specificity for recognizing and capturing biomarkers. Partially complementary DNA-attached gold nanoparticles (AuNPs) are employed to efficiently hybridize with the remaining aptamer to quench the fluorescence of QDs by nanometal surface energy transfer (NSET) between them both, which are constructed for prostate specific antigen (PSA) assay. Taking advantage of the networked nanostructure of aptamer-QDs/NFs, the fluorescent film can detect PSA with high sensitivity and a detection limit of 0.46 pg mL-1 , which was further applied in real clinical serum samples. Coupling the surface grafted techniques to the advanced network nanostructure of electrospun NFs, the proposed aptasensing platform can be easily extended to achieve sensitive and selective assays for other biomarkers.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app